Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer

A 44-year-old woman with advanced metastatic colon cancer received chemotherapies comprising oxaliplatin and capecitabine (XELOX), irinotecan hydrochloride, leucovorin calcium and fluorouracil irinotecan (FOLFIRI)/panitumumab and mFOLFOX6/bevacizumab. Fifteen months later, she presented with the acu...

Descripción completa

Detalles Bibliográficos
Autores principales: Katada, Eiichi, Mitsui, Akira, Sasaki, Shigeru, Uematsu, Norihiko, Anan, Chise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148172/
https://www.ncbi.nlm.nih.gov/pubmed/29526944
http://dx.doi.org/10.2169/internalmedicine.0284-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148172/
https://www.ncbi.nlm.nih.gov/pubmed/29526944
http://dx.doi.org/10.2169/internalmedicine.0284-17

Ejemplares similares